416402
Position
Chief Financial Officer and Chief Investment Officers
Company
WuXi AppTec
Bio
Dr. Edward Hu, also known as Ed, M.B.A., has been the Chief Financial Officer at WuXi AppTec Co., Ltd. and WuXi PharmaTech (Cayman) Inc. since August 2010. Dr. Hu has been Chief Investment Officer at WuXi PharmaTech (Cayman) Inc. since April 15, 2014. He serves as Chief Investment Officer at WuXi AppTec Co., Ltd., and served as its Chief Operating Officer since January 2008. He serves as Head of WuXi Corporate Venture Fund, spearheading the fund's investment strategy and portfolio management. Dr. Hu manages WuXi's finance, strategic investments, merger and acquisitions and new business building. In addition, he also manages WuXi's joint ventures with MedImmune and PRA. He is a Founding Partner at 6 Dimensions Capital. Dr. Hu served as Chief Operating Officer at WuXi PharmaTech (Cayman) Inc. from January 2008 to April 15, 2014. Dr. Hu served as an Interim Chief Financial Officer of WuXi PharmaTech (Cayman) Inc. from February 2009 to April 2010. He served as the Chief Financial Officer and Chief Operating Officer of WuXi AppTec from March 2009 to April 2014. He served as an Executive Vice President and Chief Operating Officer of WuXi AppTec from August 2007 to February 2009. He served on various roles to become a Senior Vice President and Chief Operating Officer of Tanox Inc. from October 2000 to July 2007. He has an extensive experience in operations and financial management. He served as the Executive Vice President of Operations for WuXi PharmaTech (Cayman) Inc., from August 13, 2007 to January 2008. Dr. Hu served as Senior Vice President and Chief Operating Officer of Tanox Inc., since February 1, 2006, where he managed operations, finance, IT, project management and strategic planning. He served as Vice President of Collaborative Projects and Internal Projects of Tanox Inc. from March 2004 to January 2005, Vice President of Operations since January 2005 and served as its Vice President of Financial Planning, Project & Portfolio Management. He served as director of Finance of Tanox Inc. from July 2002 until January 2004 and previously served as Associate Director of Financial Planning and Analysis from the time he joined Tanox in October 2000. From October 2000 to July 2007, he served at Tanox, Inc. and as its Director of Finance since 2000 and also an Associate Director of Financial Planning and Analysis. From 1996 to 1998, he served as Senior Financial Analyst of Merck & Co. Inc. Dr. Hu served as Manager of business planning at Biogen Idec, Inc., from 1998 to 2000, where he managed the business planning of R&D, Clinical Operations and Business Development Support and served as its Manager of Financial Planning and Analysis. He has been a Director and Board Observer of IDEAYA Biosciences, Inc. since May 2016. He is a Director of LifeMine Therapeutics, Inc. Dr. Hu serves as a founding member of board of directors at Vivace Therapeutics. He has been Director of WuXi AppTec since March 2016. He has been Non-executive Director at WuXi Biologics (Cayman) Inc. since February 27, 2014. He served as Director of Ambrx, Inc. until September 12, 2016. He completed his Ph.D. work, all but dissertation, in at Carnegie Mellon University. He holds an M.B.A. and M.S. in Chemistry from Carnegie Mellon University, Pittsburgh, Pennsylvania.
Agenda
emergingopp_icon

Emerging Opportunities in Global Markets

11:45 AM–5:00 PM Jun 4, 2018

Room 253ABC, Level 2

Katherine AndersenHead of Healthcare Corporate Finance and East/Central Life Science atSilicon Valley Bank Michael ChanSenior VP atHKEX Helen ChenManaging Director, Head of L.E.K. China and Asia Life Sciences atL.E.K. Consulting Tony ChenPartner atJones Day Shanghei Joseph DamondExecutive Vice President, International Affairs atBiotechnology Innovation Organization Yuan-Hua DingExecutive Director and Head of External Science & Innovation atPfizer Monica H.Director, International Affairs atBiotechnology Innovation Organization Edward HuChief Financial Officer and Chief Investment Officers atWuXi AppTec Kewen JinManaging Partner atSerica Partners Alex JungPartner/Managing DIrector atEY-Parthenon Wei LiFounding Partner at6 Dimensions Capital Micah MackisonSenior VP for Corporate Development and Strategy atAssembly Biosciences Wendy PanPartner atSidley Donghui QinDirector of Innovation atFerring Pharmaceuticals Greg ScottFounder and Chairman atChinaBIO Group Victor ShiChairman atBayHelix Alan TurleyDeputy Assistant Secretary for China atU.S. Department of Commerce Jonathan WangSenior VP and Head of Business Development atZai Lab Lijun WuChief Scientific Officer and Senior VP R&D, Fosun Pharma USA atFosun Pharma USA Haishan XiongSenior Vice President for Business Development atFountain Medical Development, Ltd GE YanfengDirector-General of the Research Department of Social Development atDevelopment Research Center of the State Council (DRC) Debra YuManaging Director atChina Renaissance Securities (US) Inc.
Interests
None yet.